Deutsche Bank’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Deutsche Bank’s Portfolio NVIV Stock Details NVIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6	Closed	-$3K	–	5574
2019 Q2	$3K	Buy	+6	New	+$5.27K	﹤0.01%	5166
2018 Q2	–	Hold	0	–	–	–	5781
2018 Q1	–	Hold	0	–	–	–	5782
2017 Q4	–	Hold	0	–	–	–	5281
2017 Q3	–	Sell	-2	Closed	-$61.5K	–	5250
2017 Q2	$111K	Buy	+2	New	+$109K	﹤0.01%	4174
2017 Q1	–	Sell	-1	Closed	-$80.8K	–	4372
2016 Q4	$80K	Buy	+1	New	+$89.4K	﹤0.01%	4181
2016 Q3	–	Hold	0	–	–	–	4206
2016 Q2	–	Sell	-2	Closed	-$235K	–	4653
2016 Q1	$255K	Buy	+2	New	+$215K	﹤0.01%	3542
2015 Q4	–	Hold	0	–	–	–	4440
2015 Q3	–	Hold	0	–	–	–	4329
2015 Q2	–	Hold	0	–	–	–	4084

Other funds holding NVIV

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PWM

Paulson Wealth Management Wheaton, Illinois $427M AUM 16.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NCM

Next Capital Management New York $330M AUM 11.54% 1-Year Est. Return

Deutsche Bank's NVIV Position: Q3 2019 in Review

Deutsche Bank sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q3 2019, closing a stake of 6 shares — an estimated $3K sold.

Deutsche Bank first reported a position in NVIV in Q1 2016 and held it in 4 quarters. The position peaked at $255K in Q1 2016. 12 funds tracked by Wall St. Rank hold NVIV as of Q3 2019.

Deutsche Bank reported no remaining InVivo Therapeutics Holdings Corp position as of Q3 2019 after selling out during the quarter.
Deutsche Bank sold 6 InVivo Therapeutics Holdings Corp shares in Q3 2019, an estimated $3K.
Deutsche Bank first reported a position in InVivo Therapeutics Holdings Corp in Q1 2016 and held it in 4 quarters.
Deutsche Bank's InVivo Therapeutics Holdings Corp position peaked at $255K in Q1 2016.
12 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q3 2019.

Based on Deutsche Bank's 13F filing for Q3 2019, filed 14 Nov 2019.